Welcome To The Resverlogix HUB On AGORACOM

**Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Trial and a Phase 2 Kidney Trial is Planned for 2017**


AGORACOM Welcomes Back Grizzly Discoveries (GZD: TSX-V)

World class gold and base metal deposits in British Columbia; and diamonds in Alberta $GZD.ca

  • More than 9 million oz Au produced or as resources in a radius of less than 70KM to Greenwood project
  • Holds, or has an interest in, metallic and industrial mineral permits for potash totaling more than 364,000 acres along the Alberta-Saskatchewan border
  • Drillholes with up to 31.1% K2O from assays on recent drill program
  • Portions of Greenwood Project being explored by Kinross through option agreement


Hub On AGORACOM / Learn More!



Namaste Announces Signing of MOU With Marijuana.Ca

  • Entered MOU with Marijuana.Ca, operator of www.marijuana.ca
  • Signing of MOU represents further achievement of the Company’s objective to increase site traffic and develop customer data in the Canadian market
  • Also coincides with the upcoming launch of www.everyonedoesit.ca, which the Company will use to further expand its position in the Canadian market



Hub On AGORACOM / Read Release


Tetra Bio-Pharma Announces the Initiation of its Phase I Trial of dried Cannabis

  • Announces launch of its Double-Blind Phase I Study
  • Purpose to Assess Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single and Multiple Daily Ascending Doses of Cannabis by Smoking/Inhalation in Healthy Male and Female Volunteers
  • Trial activities will occur over a 3 to 4-month period and involve site initiation, subject recruitment and enrolment, a single daily ascending dose phase and a 7-day multiple daily ascending dose phase, followed by study termination

Tbp large

Hub On AGORACOM / Read Release

Message: A few comments...

I have gone to post a few times and pulled them.

Remember as a child or a teen and your dream was to grow up and be a "?". Then you discovered something and that became your goal?

When spinco was formed RVX was going to grow up and produce a "pharmaceutical product (which) elevate(s) plasma levels of a certain lipoprotein associated with a decreased risk of atherosclerosis and coronary heart disease.

Well they grew up and in so doing realized that they were limiting their potential by the adolescent dream...

...detailed study of the results of the Corporation’s clinical trial program indicates that apabetalone/RVX-208 has been shown to affect expression of numerous targets important for cardiovascular disease and ApoA-1 is only one of these targets. Therefore, the Corporation has determined that it is necessary to amend the terms of the Royalty Preferred Shares to remove the requirement that the pharmaceutical agent elevate plasma levels of ApoA-1.

I don't look back too many times regretting not becoming what I wanted when I was a child.

New Message
Please login to post a reply